#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of Crizotinib and Temsirolimus for Children with ALK, ROS1, or MET Positive Cancers, Including Neuroblastoma and Rhabdomyosarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Finland France Germany Italy The Netherlands +3

  • Study on the Safety and Dosage of GD2IL18CART for Patients with Relapsed or Refractory GD2 Positive Solid Cancers

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on Dinutuximab Beta with Chemotherapy for Children and Teens with Newly Diagnosed High-Risk Neuroblastoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Austria France Germany Italy The Netherlands Poland +1

  • Study of Lutetium (177Lu) Oxodotreotide for Children with Relapsed or Refractory High-Risk Neuroblastoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Denmark Lithuania The Netherlands Norway Spain Sweden

  • Feasibility Study of AloCelyvir and Autologous Tumor‑Infiltrating T Lymphocytes in Children and Young Adults with High‑Risk Relapsed/Refractory Neuroblastoma

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study of Anti-GD2-800CW for Imaging in Children with Neuroblastoma

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    The Netherlands

  • Study of ABTL0812 with Irinotecan and Temozolomide for Children with Relapsed or Refractory Neuroblastoma and Other Solid Tumors

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Spain

  • Study on the Safety of 68Ga-SATO and Iodine (123I) Iobenguane in Children with Neuroblastoma

    Not yet recruiting

    1 1 1 1
    Investigated Drugs:
    The Netherlands

  • Study on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients

    Not yet recruiting

    3 1 1 1
    Investigated Drugs:
    Germany

  • Study on the Safety of Lutetium (177Lu) Oxodotreotide with Arginine and Lysine in Children with Refractory or Recurrent Neuroblastoma

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France